Back to search results

Wearable Device for Heart Health in Cancer Patients

This study is developing a new wearable sensor system to measure how well your heart is pumping, specifically your left ventricular ejection fraction (LVEF). LVEF is a key indicator of heart function. The goal is to see how well the measurements from this wearable device match up with measurements from a standard heart ultrasound (transthoracic echocardiography or TTE). You might be able to join if you are 18 or older, are already having a TTE, and are willing to give your informed consent. The study is looking to enroll up to 500 participants. The study's status is currently unclear.

Study design
This is an observational study, meaning researchers will collect information without giving you any specific intervention. It plans to enroll up to 500 participants.
What's involved
You would need to be undergoing an echocardiogram and provide informed consent. The study will compare wearable measurements with your echocardiogram results for up to 6 months.
Compensation
Not stated in the trial record.
Follow-up
Your heart measurements will be compared from baseline through study completion, which can be up to 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07158450

Novel On-body Evaluation of Cardiac Health for Oncology

Enrolling by Invitation
Not specifiedAges 18+Observational
Skribe Medical
~500 participants
Updated 2026-05-20 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Correlation between wearable-derived and transthoracic echocardiography-derived left ventricular ejection fraction estimates
Measured over From baseline through study completion (up to 6 months) at each paired assessment

Conditions

Cardiotoxicity
Heart Failure

Explore related trials

CardiotoxicityHeart Failure

NCT07158450

Where you'd take part

This study runs at 7 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Cardiology Consultants of Philadelphia

    Yardley, Pennsylvaniano site contact published

  • Cardiovascular Institute of the South

    Houma, Louisianano site contact published

  • Clearwater Cardiovascular Consultants

    Clearwater, Floridano site contact published

  • Colorado Heart and Vascular

    Golden, Coloradono site contact published

  • Midwest Cardiovascular Institute

    Naperville, Illinoisno site contact published

  • Stern Cardiovascular Center

    Germantown, Tennesseeno site contact published

  • Strong Memorial Hospital

    Rochester, New Yorkno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Undergoing an echocardiogram irrespective of participation in this study
Willing and able to provide informed consent prior to any study-related activity

Exclusion

Have a documented allergy to potential tissue contacting system materials
Have any condition that would cause inaccurate TTE measurements

What this trial measures

  • Correlation between wearable-derived and transthoracic echocardiography-derived left ventricular ejection fraction estimatesFrom baseline through study completion (up to 6 months) at each paired assessment

    The primary analysis will compute the correlation coefficient (r) between wearable-derived model estimates of LVEF and transthoracic echocardiography-derived LVEF in the Hold-Out Test Set. The prespecified performance target is r \> 0.70.